Keywords: corvas, reports, rnapc2, trial, angioplasty, international, said

Corvas reports rNAPc2 trial in angioplasty

Article | 06 December 2001

Print This

Corvas International has said that it intends to press on with a PhaseII study of its anticoagulant rNAPc2 in patients ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in